GH1 and hereditary endocrine growth disease: Importantly, other evaluated clinical parameters, including birth parameters, body disproportionality, severity of growth disorder or response to GH treatment, did not differ significantly in children with monogenic FSS compared to those with no monogenic etiology of FSS elucidated (Table 1).